本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

18.03
-0.1700-0.93%
盘后18.800.7700+4.27%18:13 EDT
成交量:179.14万
成交额:3,241.70万
市值:22.63亿
市盈率:-11.29
高:18.72
开:18.00
低:17.68
收:18.20
数据加载中...
2025/04/21

重要事件披露

Form 8-K - Current report
2025/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities